- Home
- INTT vs APLT Comparison
INTT vs APLT Comparison
Compare INTT & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTT
- APLT
- Stock Information
- Founded
- INTT 1981
- APLT 2016
- Country
- INTT United States
- APLT United States
- Employees
- INTT N/A
- APLT N/A
- Industry
- INTT Semiconductors
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- INTT Technology
- APLT Health Care
- Exchange
- INTT Nasdaq
- APLT Nasdaq
- Market Cap
- INTT 77.3M
- APLT 44.0M
- IPO Year
- INTT 1997
- APLT 2019
- Fundamental
- Price
- INTT $7.30
- APLT $0.40
- Analyst Decision
- INTT Strong Buy
- APLT Buy
- Analyst Count
- INTT 2
- APLT 7
- Target Price
- INTT $12.00
- APLT $6.10
- AVG Volume (30 Days)
- INTT 29.8K
- APLT 2.6M
- Earning Date
- INTT 08-01-2025
- APLT 08-06-2025
- Dividend Yield
- INTT N/A
- APLT N/A
- EPS Growth
- INTT N/A
- APLT N/A
- EPS
- INTT N/A
- APLT N/A
- Revenue
- INTT $127,503,000.00
- APLT $265,000.00
- Revenue This Year
- INTT N/A
- APLT $1,768.13
- Revenue Next Year
- INTT $10.07
- APLT $292.85
- P/E Ratio
- INTT N/A
- APLT N/A
- Revenue Growth
- INTT 5.19
- APLT N/A
- 52 Week Low
- INTT $5.24
- APLT $0.30
- 52 Week High
- INTT $11.92
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- INTT 58.40
- APLT 58.87
- Support Level
- INTT $7.01
- APLT $0.32
- Resistance Level
- INTT $8.14
- APLT $0.36
- Average True Range (ATR)
- INTT 0.45
- APLT 0.04
- MACD
- INTT 0.02
- APLT 0.01
- Stochastic Oscillator
- INTT 63.38
- APLT 94.92
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.